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Background: We have recently developed Gd3+-containing carbon nanocapsules, or gadonanotubes (GNTs), as a high-performance T1-
weighted magnetic resonance imaging (MRI) contrast agent. In this present study, the biological effects and cell labeling performance of GNTs in 
mesenchymal stem cells (MSCs) were examined for cellular T1-weighted MRI.
Methods: MSCs were cultured with GNTs (27μM Gd) in medium for 24 h. The effects of the GNTs on MSC viability and function were analyzed by 
pulse chase labeling, flow cytometry, clonogenic, and differentiation assays. T1 analyses of unlabeled and GNT-labeled cell pellets were acquired 
using a 1.5 T clinical MRI scanner.
Results: GNTs can deliver up to 1010 Gd3+ ions per cell with 98% cell viability without a transfection agent. Cell proliferation of GNT-labeled MSCs 
(PDT=7.36 h, CFU=827±18) was comparable to that of control cells (PDT=9.31 h, CFU=686±97). GNT-labeled MSCs exhibited CD29+CD45-CD90+ 
phenotype and differentiated into adipocytes and osteocytes. The T1 relaxation time of the GNT-labeled MSC pellet (434 ms) was reduced more than 
two-fold when compared to that of unlabeled MSCs (1159 ms). This allows discrimination of GNT-labeled MSCs in a T1-weighted MR image (Fig1).
Conclusions: GNTs can be internalized by MSCs without compromising cell viability, phenotype, proliferation pattern, and 
differentiation potential. The GNTs may be the first effective T1-weighted MRI contrast agent used for the in vivo tracking of MSCs.
